High-Risk Human Papillomavirus Oncogenic E6/E7 mRNAs Splicing Regulation

High-Risk Human Papillomavirus Oncogenic E6/E7 mRNAs Splicing Regulation

High-risk human papillomavirus infection may develop into a persistent infection that is highly related to the progression of various cancers, including cervical cancer and head and neck squamous cell carcinomas. The most common high-risk subtypes are HPV16 and HPV18. The oncogenic viral proteins ex...

Full description

Bibliographic Details
Main Authors:	Yunji Zheng, Xue Li, Yisheng Jiao, Chengjun Wu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-06-01
Series:	Frontiers in Cellular and Infection Microbiology
Subjects:	high-risk HPVs cervical cancer HNSCC E6/E7 splicing splicing factors
Online Access:	https://www.frontiersin.org/articles/10.3389/fcimb.2022.929666/full

Similar Items

The Role of E6 Spliced Isoforms (E6*) in Human Papillomavirus-Induced Carcinogenesis
by: Leslie Olmedo-Nieva, et al.
Published: (2018-01-01)

Splicing and Polyadenylation of Human Papillomavirus Type 16 mRNAs
by: Chengjun Wu, et al.
Published: (2017-02-01)

Reply to Wang et al., “Assessment of the Abundance and Potential Function of Human Papillomavirus Type 16 Circular E7 RNA”
by: Lulu Yu, et al.
Published: (2022-06-01)

Human Virome in Cervix Controlled by the Domination of Human Papillomavirus
by: Thanayod Sasivimolrattana, et al.
Published: (2022-09-01)

REBACIN® inhibits E6/E7 oncogenes in clearance of human papillomavirus infection
by: Shu-Guang Zhou, et al.
Published: (2022-12-01)

Genetic variations and alternative splicing. The Glioma associated oncogene 1, GLI1.
by: Peter eZaphiropoulos
Published: (2012-07-01)

Papillomavirus Immune Evasion Strategies Target the Infected Cell and the Local Immune System
by: Chenhao Zhou, et al.
Published: (2019-08-01)

Detection of Human Papillomaviruses in the Nasopharynx of Breastfed Infants: New Findings and Meta-Analysis
by: Luisa Dassi, et al.
Published: (2020-10-01)

Construction of an immune-related ceRNA network in cervical cancer based on HPV E6 splicing
by: Senwei Jiang, et al.
Published: (2022-12-01)

Alternative Splicing and Isoforms: From Mechanisms to Diseases
by: Qi Liu, et al.
Published: (2022-02-01)

Human Papillomavirus Type 16 Circular RNA Is Barely Detectable for the Claimed Biological Activity
by: Lulu Yu, et al.
Published: (2022-02-01)

Splice and Dice: Intronic microRNAs, Splicing and Cancer
by: Alex C. H. Wong, et al.
Published: (2021-09-01)

Prognostic Value and Potential Role of Alternative mRNA Splicing Events in Cervical Cancer
by: Xiang-yang Shao, et al.
Published: (2020-07-01)

How Driver Oncogenes Shape and Are Shaped by Alternative Splicing Mechanisms in Tumors
by: Weronika Wojtyś, et al.
Published: (2023-05-01)

Punicalagin promotes autophagic degradation of human papillomavirus E6 and E7 proteins in cervical cancer through the ROS-JNK-BCL2 pathway
by: Xialin Xie, et al.
Published: (2022-05-01)

Modularized Perturbation of Alternative Splicing Across Human Cancers
by: Yabing Du, et al.
Published: (2019-04-01)

Regulation of RNA Splicing: Aberrant Splicing Regulation and Therapeutic Targets in Cancer
by: Koji Kitamura, et al.
Published: (2021-04-01)

Corrigendum: Modularized Perturbation of Alternative Splicing Across Human Cancers
by: Yabing Du, et al.
Published: (2019-10-01)

Knockout of circRNAs by base editing back-splice sites of circularized exons
by: Xiang Gao, et al.
Published: (2022-01-01)

Splicing alterations in pancreatic ductal adenocarcinoma: a new molecular landscape with translational potential
by: Emilia Alors-Pérez, et al.
Published: (2023-10-01)

SPLICE-q: a Python tool for genome-wide quantification of splicing efficiency
by: Verônica R. de Melo Costa, et al.
Published: (2021-07-01)

RNA splicing alterations in lung cancer pathogenesis and therapy
by: Yueren Yan, et al.
Published: (2023-10-01)

Biology of the mRNA Splicing Machinery and Its Dysregulation in Cancer Providing Therapeutic Opportunities
by: Maxime Blijlevens, et al.
Published: (2021-05-01)

Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy
by: Asmita Pal, et al.
Published: (2020-01-01)

Relationship between vaginal microecological changes and oncogene E6/E7 and high-risk human papillomavirus infection
by: Jun Huang, et al.
Published: (2023-12-01)

Therapeutic potential of alternative splicing in cardiovascular diseases
by: Jun Cao, et al.
Published: (2024-03-01)

Aberrant RNA Splicing in Cancer and Drug Resistance
by: Bi-Dar Wang, et al.
Published: (2018-11-01)

Functional analyses of human LUC7-like proteins involved in splicing regulation and myeloid neoplasms
by: Noah J. Daniels, et al.
Published: (2021-04-01)

Evolution of the Early Spliceosomal Complex—From Constitutive to Regulated Splicing
by: Sonia Borao, et al.
Published: (2021-11-01)

Targeted splicing therapy: new strategies for colorectal cancer
by: Yifeng Zheng, et al.
Published: (2023-08-01)

Towards Splicing Therapy for Lysosomal Storage Disorders: Methylxanthines and Luteolin Ameliorate Splicing Defects in Aspartylglucosaminuria and Classic Late Infantile Neuronal Ceroid Lipofuscinosis
by: Antje Banning, et al.
Published: (2021-10-01)

High-risk HPVs and human carcinomas in the Syrian population
by: Ala-Eddin eAl Moustafa, et al.
Published: (2014-04-01)

Deciphering the plant splicing code: Experimental and computational approaches for predicting alternative splicing and splicing regulatory elements
by: Anireddy S.N. Reddy, et al.
Published: (2012-02-01)

The Role of Long Noncoding RNAs in Human Papillomavirus-associated Pathogenesis
by: Surendra Sharma, et al.
Published: (2020-04-01)

Prevalence of type-specific oncogenic human papillomavirus infection assessed by HPV E6/E7 mRNA among women with high-grade cervical lesions
by: Hye-young Wang, et al.
Published: (2015-08-01)

SplicedFamAlign: CDS-to-gene spliced alignment and identification of transcript orthology groups
by: Safa Jammali, et al.
Published: (2019-03-01)

COL3A1: Potential prognostic predictor for head and neck cancer based on immune‐microenvironment alternative splicing
by: Yuchen Shen, et al.
Published: (2023-02-01)

RNAi-Mediated Knockdown of Cottontail Rabbit Papillomavirus Oncogenes Using Low-Toxicity Lipopolyplexes as a Paradigm to Treat Papillomavirus-Associated Cancers
by: Uzma Ali, et al.
Published: (2023-09-01)

E6/E7 Variants of Human Papillomavirus 16 Associated with Cervical Carcinoma in Women in Southern Mexico
by: Ramón Antaño-Arias, et al.
Published: (2021-06-01)

Occipital Horn Syndrome as a Result of Splice Site Mutations in ATP7A. No Activity of ATP7A Splice Variants Missing Exon 10 or Exon 15
by: Lisbeth Birk Møller, et al.
Published: (2021-04-01)